CordovaCann (LVRLF) Total Non-Current Liabilities (2009 - 2020)

CordovaCann (LVRLF) recorded quarterly Total Non-Current Liabilities of $6.0 million in Q2 2020, up 86.73% quarter-over-quarter from $3.2 million in Q2 2019, and up 86.73% on a YoY basis from $3.2 million in Q3 2019.

CordovaCann (LVRLF) Total Non-Current Liabilities (2009 - 2020) Analysis & Trends

CordovaCann's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $6.0 million for Q2 2020.

  • In Q2 2020, Total Non-Current Liabilities rose 86.73% year-over-year to $6.0 million; the TTM figure through Jun 2020 stood at $6.0 million (up 86.73% YoY), while the FY2020 annual figure was $6.2 million, up 90.98% from the prior year.
  • Total Non-Current Liabilities was $6.0 million for Q2 2020 at CordovaCann, up from $3.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $6.0 million in Q2 2020 to a low of $3.2 million in Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 CordovaCann - - - -

Historic Data

Download Data
DateValue
Jun 30, 2020 5.98 Mn
Jun 30, 2019 3.20 Mn
Sep 30, 2010 -1.10 Mn
Mar 31, 2010 -1.10 Mn
Dec 31, 2009 -1.09 Mn
Sep 30, 2009 -1.04 Mn
Jun 30, 2009 -981,233.05
Mar 31, 2009 -922,152.39